162 related articles for article (PubMed ID: 23322534)
21. [Correlations between serine hydroxymethyltransferase1 C1420T polymorphisms and susceptibilities to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Wang YM; Guo W; Zhang XF; Li Y; Wang N; Ge H; Wei LZ; Wen DG; Zhang JH
Ai Zheng; 2006 Mar; 25(3):281-6. PubMed ID: 16536979
[TBL] [Abstract][Full Text] [Related]
22. Interaction between Maternal and Paternal SHMT1 C1420T Predisposes to Neural Tube Defects in the Fetus: Evidence from Case-Control and Family-Based Triad Approaches.
K Rebekah P; Tella S; Buragadda S; Tiruvatturu MK; Akka J
Birth Defects Res; 2017 Jul; 109(13):1020-1029. PubMed ID: 28762673
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis.
Wang L; Lu J; An J; Shi Q; Spitz MR; Wei Q
Lung Cancer; 2007 Aug; 57(2):143-51. PubMed ID: 17420066
[TBL] [Abstract][Full Text] [Related]
24. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
Xie M; Zhao F; Zou X; Jin S; Xiong S
Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
[TBL] [Abstract][Full Text] [Related]
25. GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
Tan Z; Feng M; Luo Y; Sun C; Fan Z; Tan Y; Fu B; Lang J
Gene; 2013 Sep; 527(1):275-82. PubMed ID: 23811488
[TBL] [Abstract][Full Text] [Related]
26. Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab.
Budai B; Komlósi V; Adleff V; Pap É; Réti A; Nagy T; Kralovánszky J; Láng I; Hitre E
Pharmacogenet Genomics; 2012 Jan; 22(1):69-72. PubMed ID: 22044939
[TBL] [Abstract][Full Text] [Related]
27. Tumor Reliance on Cytosolic versus Mitochondrial One-Carbon Flux Depends on Folate Availability.
Lee WD; Pirona AC; Sarvin B; Stern A; Nevo-Dinur K; Besser E; Sarvin N; Lagziel S; Mukha D; Raz S; Aizenshtein E; Shlomi T
Cell Metab; 2021 Jan; 33(1):190-198.e6. PubMed ID: 33326752
[TBL] [Abstract][Full Text] [Related]
28. Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk.
Macfarlane AJ; Perry CA; McEntee MF; Lin DM; Stover PJ
Cancer Res; 2011 Mar; 71(6):2098-107. PubMed ID: 21406397
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.
Peng Q; Yang S; Lao X; Tang W; Chen Z; Lai H; Wang J; Sui J; Qin X; Li S
PLoS One; 2014; 9(4):e94790. PubMed ID: 24733273
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma.
Skibola CF; Forrest MS; Coppedé F; Agana L; Hubbard A; Smith MT; Bracci PM; Holly EA
Blood; 2004 Oct; 104(7):2155-62. PubMed ID: 15198953
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan.
Cheng CW; Yu JC; Huang CS; Shieh JC; Fu YP; Wang HW; Wu PE; Shen CY
Breast Cancer Res Treat; 2008 Sep; 111(1):145-55. PubMed ID: 17896178
[TBL] [Abstract][Full Text] [Related]
32. Differential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogramming.
Paiardini A; Tramonti A; Schirch D; Guiducci G; di Salvo ML; Fiascarelli A; Giorgi A; Maras B; Cutruzzolà F; Contestabile R
Biochim Biophys Acta; 2016 Nov; 1864(11):1506-17. PubMed ID: 27530298
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study.
Chen J; Kyte C; Valcin M; Chan W; Wetmur JG; Selhub J; Hunter DJ; Ma J
Int J Cancer; 2004 Jul; 110(4):617-20. PubMed ID: 15122597
[TBL] [Abstract][Full Text] [Related]
34. Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis.
Pabalan N; Francisco-Pabalan O; Jarjanazi H; Li H; Sung L; Ozcelik H
Mol Biol Rep; 2012 Dec; 39(12):11061-72. PubMed ID: 23073772
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer risk associated with multigenotypic polymorphisms in folate-metabolizing genes: a nested case-control study in Taiwan.
Yu CP; Wu MH; Chou YC; Yang T; You SL; Chen CJ; Sun CA
Anticancer Res; 2007; 27(3B):1727-32. PubMed ID: 17595805
[TBL] [Abstract][Full Text] [Related]
36. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis.
Zheng Y; Wang JJ; Sun L; Li HL
Mol Biol Rep; 2012 Apr; 39(4):3533-40. PubMed ID: 21710246
[TBL] [Abstract][Full Text] [Related]
37. Drosha-independent miR-6778-5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism.
Zhao M; Hou Y; Du YE; Yang L; Qin Y; Peng M; Liu S; Wan X; Qiao Y; Zeng H; Cui X; Teng Y; Liu M
Cancer Lett; 2020 May; 478():8-21. PubMed ID: 32142918
[TBL] [Abstract][Full Text] [Related]
38. Common genetic variant on BMP4 contributes to colorectal adenoma and cancer: A meta-analysis based on 15 studies.
Zhou L; Xie J; Gu EL; Huang Y; Qu Y; Xu AP; Zhu Y; Wang H
Cytokine; 2015 Apr; 72(2):154-9. PubMed ID: 25647270
[TBL] [Abstract][Full Text] [Related]
39. The moonlighting RNA-binding activity of cytosolic serine hydroxymethyltransferase contributes to control compartmentalization of serine metabolism.
Guiducci G; Paone A; Tramonti A; Giardina G; Rinaldo S; Bouzidi A; Magnifico MC; Marani M; Menendez JA; Fatica A; Macone A; Armaos A; Tartaglia GG; Contestabile R; Paiardini A; Cutruzzolà F
Nucleic Acids Res; 2019 May; 47(8):4240-4254. PubMed ID: 30809670
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in folate metabolizing genes and risk for spontaneous preterm and small-for-gestational age birth.
Engel SM; Olshan AF; Siega-Riz AM; Savitz DA; Chanock SJ
Am J Obstet Gynecol; 2006 Nov; 195(5):1231.e1-11. PubMed ID: 17074544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
